Applied Dna Sciences Gross Profit

The latest gross profit for APDN is $1.4M as of June 2026. That compares with $1.3M in the prior-year period — up 4.8% year over year. That is below the Materials sector average of $46B. Investors often review this figure alongside Applied Dna Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, APDN's gross profit moved from $1.3M to $1.4M — a 4.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Applied Dna Sciences's operating scale or balance-sheet position.

Against Materials companies, APDN currently prints $1.4M for gross profit, while the sector average sits near $46B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Applied Dna Sciences's growth, margins, and balance sheet.

A gross profit figure of $1.4M for APDN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Materials average is about $46B. Explore the charts below for those layers of context.

After noting APDN's gross profit ($1.4M), review year-over-year change from $1.3M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.